R1 RCM (NASDAQ:RCM) Lowered to “Hold” at ValuEngine

R1 RCM (NASDAQ:RCM) was downgraded by analysts at ValuEngine from a “buy” rating to a “hold” rating in a note issued to investors on Wednesday, ValuEngine reports.

Several other research analysts also recently commented on the company. Robert W. Baird set a $14.00 target price on R1 RCM and gave the stock a “buy” rating in a research note on Thursday, September 12th. BidaskClub downgraded R1 RCM from a “sell” rating to a “strong sell” rating in a research note on Tuesday, October 1st. Finally, Zacks Investment Research downgraded R1 RCM from a “buy” rating to a “hold” rating in a research note on Tuesday, August 13th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and four have issued a buy rating to the company’s stock. The company currently has an average rating of “Hold” and a consensus target price of $14.20.

Shares of NASDAQ RCM traded up $0.24 during midday trading on Wednesday, hitting $9.38. 1,279,803 shares of the company’s stock were exchanged, compared to its average volume of 1,249,180. The company has a quick ratio of 0.90, a current ratio of 0.90 and a debt-to-equity ratio of 106.30. R1 RCM has a 12 month low of $7.10 and a 12 month high of $13.19. The company’s 50 day moving average price is $10.82 and its 200 day moving average price is $11.40. The firm has a market capitalization of $1.03 billion, a PE ratio of -29.31 and a beta of 0.10.

R1 RCM (NASDAQ:RCM) last issued its earnings results on Tuesday, August 6th. The financial services provider reported ($0.09) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.01) by ($0.08). R1 RCM had a negative return on equity of 249.01% and a negative net margin of 2.22%. The business had revenue of $295.00 million for the quarter, compared to the consensus estimate of $294.11 million. During the same quarter in the prior year, the firm posted ($0.07) earnings per share. The business’s revenue was up 41.9% compared to the same quarter last year. On average, equities research analysts anticipate that R1 RCM will post 0.06 EPS for the current year.

Hedge funds and other institutional investors have recently modified their holdings of the company. SG Americas Securities LLC bought a new stake in R1 RCM in the 1st quarter valued at $142,000. US Bancorp DE boosted its stake in R1 RCM by 315.7% in the 1st quarter. US Bancorp DE now owns 39,555 shares of the financial services provider’s stock valued at $382,000 after purchasing an additional 30,039 shares during the period. PNC Financial Services Group Inc. boosted its stake in R1 RCM by 5,468.3% in the 1st quarter. PNC Financial Services Group Inc. now owns 415,564 shares of the financial services provider’s stock valued at $4,020,000 after purchasing an additional 408,101 shares during the period. Campbell & CO Investment Adviser LLC bought a new stake in R1 RCM in the 1st quarter valued at $339,000. Finally, Hennessy Advisors Inc. bought a new stake in R1 RCM in the 2nd quarter valued at $3,589,000. Institutional investors own 70.75% of the company’s stock.

R1 RCM Company Profile

R1 RCM Inc provides revenue cycle management (RCM) for healthcare providers in the United States. It offers end-to-end RCM services to manage their revenue cycle operations, which encompass patient registration, insurance and benefit verification, medical treatment documentation and coding, and bill preparation and collection from patients and payers.

Read More: Trading Options- What is a Strangle?

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Ratings for R1 RCM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for R1 RCM and related companies with MarketBeat.com's FREE daily email newsletter.